基于高敏肌钙蛋白和HEART评分的排除策略减少住院率
这项前瞻性观察性多中心研究在2013—2014年(实施前)和2015—2016年(实施后)比较了1小时高敏肌钙蛋白T或I算法联合HEART评分排除急性冠脉综合征的策略。基线高敏肌钙蛋白不升高且1小时变化高敏肌钙蛋白T<3 ng/L或高敏肌钙蛋白I<6 ng/L、HEART评分≤3分的患者被认为可排除急性冠脉综合征。共纳入6个中心1233例患者,实施后住院率从59%降至33%(风险比0.55,95%CI 0.48~0.63),中位住院时间从23.2小时降至4.7小时,中位医疗费用从1748美元降至1079美元,临床事件数量极少。
要点
- 疑似急性冠脉综合征患者,基线高敏肌钙蛋白不升高且1小时变化高敏肌钙蛋白T<3 ng/L或高敏肌钙蛋白I<6 ng/L、HEART评分≤3分者可排除急性冠脉综合征。
- 实施该排除策略后住院率从59%降至33%,风险比0.55(95%CI 0.48~0.63),调整后比值比0.33(95%CI 0.25~0.42)。
- 中位住院时间从23.2小时缩短至4.7小时(差值95%CI -20.4~-11.4小时)。
- 中位医疗费用从1748美元降至1079美元(差值95%CI -953~-391美元)。
- 临床事件数量极少。
适用人群与场景
- 有提示急性冠脉综合征症状的患者,纳入6个中心的前瞻性观察性研究。
诊断标准与关键阈值
- 排除急性冠脉综合征标准:基线高敏肌钙蛋白不升高,且1小时变化高敏肌钙蛋白T<3 ng/L或高敏肌钙蛋白I<6 ng/L,同时HEART评分≤3分。
处置流程与药物剂量
- 采用0和1小时高敏肌钙蛋白T或I检测,联合HEART评分;符合上述排除标准者被认为可排除急性冠脉综合征。
研究设计与关键结果
- 前瞻性观察性多中心研究,实施前(2013—2014年)与实施后(2015—2016年)比较,共纳入6个中心1233例患者。
- 实施后住院率从59%降至33%,风险比0.55(95%CI 0.48~0.63),比值比0.33(95%CI 0.26~0.42),调整后比值比0.33(95%CI 0.25~0.42)。
- 中位住院时间从23.2小时降至4.7小时(差值95%CI -20.4~-11.4小时)。
- 中位医疗费用从1748美元降至1079美元(差值95%CI -953~-391美元)。
- 临床事件数量极少。
证据类型、等级与局限
- 证据类型:前瞻性观察性多中心研究(前后对照设计)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,1小时高敏肌钙蛋白算法联合HEART评分的临床实施与住院率和医疗负担降低相关,且不良临床事件率极低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We evaluate whether a combination of a 1-hour high-sensitivity cardiac troponin algorithm and History, ECG, Age, Risk Factors, and Troponin (HEART) score reduces admission rate (primary outcome) and affects time to discharge, health care-related costs, and 30-day outcome (secondary outcomes) in patients with symptoms suggestive of an acute coronary syndrome.
METHODS: This prospective observational multicenter study was conducted before (2013 to 2014) and after (2015 to 2016) implementation of a strategy including level of high-sensitivity cardiac troponin T or I at 0 and 1 hour, combined with the HEART score. Patients with a nonelevated baseline high-sensitivity cardiac troponin level, a 1-hour change in high-sensitivity cardiac troponin T level less than 3 ng/L, or high-sensitivity cardiac troponin I level less than 6 ng/L and a HEART score less than or equal to 3 were considered to be ruled out of having acute coronary syndrome. A logistic regression analysis was performed to adjust for differences in baseline characteristics.
RESULTS: A total of 1,233 patients were included at 6 centers. There were no differences in regard to median age (64 versus 63 years) and proportion of men (57% versus 54%) between the periods. After introduction of the new strategy, the admission rate decreased from 59% to 33% (risk ratio 0.55 [95% confidence interval {CI} 0.48 to 0.63]; odds ratio 0.33 [95% CI 0.26 to 0.42]; adjusted odds ratio 0.33 [95% CI 0.25 to 0.42]). The median hospital stay was reduced from 23.2 to 4.7 hours (95% CI of difference -20.4 to -11.4); median health care-related costs, from $1,748 to $1,079 (95% CI of difference -$953 to -$391). The number of clinical events was very low.
CONCLUSION: In this before-after study, clinical implementation of a 1-hour high-sensitivity cardiac troponin algorithm combined with the HEART score was associated with a reduction in admission rate and health care burden, with very low rates of adverse clinical events.
参考来源
- Ljung L, Lindahl B, Eggers KM, et al. A Rule-Out Strategy Based on High-Sensitivity Troponin and HEART Score Reduces Hospital Admissions. Ann Emerg Med. 2019. PMID: 30661856. doi:10.1016/j.annemergmed.2018.11.039
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。